Seite - 15 - in Cancer Nanotheranostics - What Have We Learnd So Far?
Bild der Seite - 15 -
Text der Seite - 15 -
Condeetal. Biofunctionalizationandsurfacechemistryof inorganicnanoparticles
FIGURE5 |Goldnanoparticles functionalizedwithmultiple
biomolecules:PEG,cellpenetrationpeptide (TAT),ammonium
quaternarygroups,andsiRNA.Twodifferent approacheswereemployed
toconjugate thesiRNAto theAuNPs: (A) ionic approach, interactionof the
negatively chargedsiRNAto themodifiedsurfaceof theAuNPs through
ionic interactions; (B)covalent approach,useof thiolatedsiRNAforgold
thiol binding to theNPs.
point-of-care testing, gene expression studies, high-throughput
screening,andclinicaldiagnostics.
WhenmodifiedwithDNA,QDswere successfully employed
in the detection of respective complementary DNA strands via
FRET.Sub-nanomolardetectionlimitshavebeenreported(Zhou
et al., 2008a; Singh and Strouse, 2010). The strategy success
is directly related to the covalent coupling of the nucleic acid
molecule to the QD, controlling the donor-acceptor distance,
fundamental inFRET-basedbiosensors.
QDscanalsobeused ingenedelivery. Jin-MingLietal.devel-
opeda series ofQDs functionalizedwithβ-cyclodextrin coupled
toaminoacids.Usingtheβ-cyclodextrinasavector fordelivering
doxorubicin (DOX) and electrostatically bindingMDR1 siRNA,
this strategy allowed for simultaneous chemotherapy and gene
silencing. The authors observed that in HeLa cells it was pos-
sible to induce apoptosis due to the intracellular accumulation
ofDox and also reduced levels ofMDR1gene expression.These
multifunctional QDs are promising vehicles for the co-delivery
of nucleic acids and chemotherapeutics, as well as for real-time
trackingof treatment(Lietal., 2012). QDs-siRNA conjugates have also been used for imaging
and gene silencing approaches (Derfus et al., 2007; Tan et al.,
2007; Yezhelyev et al., 2008; Zhao et al., 2010; Li et al., 2011,
2012). For example, Yezhelyev et al. developedmultifunctional
nanoparticles for siRNA delivery and imaging based on the
use of QDs and proton-absorbing polymeric coatings (proton
sponges). The authors demonstrated a dramatic improvement
in gene silencing efficiency and simultaneous reduction in cel-
lular toxicity, when comparedwith existing transfection agents.
Additionally, QD-siRNA nanoparticles are also dual-modality
opticalandelectron-microscopyprobes,allowingreal-timetrack-
ing and ultrastructural localization ofQDs during delivery and
transfection(Yezhelyevetal., 2008).
MNPs have also been frequently used as platforms for the
delivery of DNA or siRNA, as they can be used to track their
biodistribution byMRI. For instance, Kumar et al. synthesized
multifunctionalMNPs by attaching a near-infrared optical dye
Cy5.5andapeptidethattargetsthetumorspecificantigenmucin-
1tocross-linkeddextrancoatedSPIONs(Kumaretal.,2010).The
delivery of thenanosystem to tumors inmicewas imaged either
invivoorexvivobyMRIandoptical imaging.
Ontheotherhand, the functionalizationofplasmidDNAand
siRNA toMNPs has been widely reported, as MNPs are used
as tools for magnetofection, that is to say, the enhanced deliv-
ery of nucleic acids associated toMNPsusing externalmagnetic
fields (Scherer et al., 2002; Dobson, 2006; Plank et al., 2011).
Using magnetofection the transfection efficiency can be highly
improved when compared with transfections carried out with
non-magnetic genedelivery systems in a variety of primary cells
and cell lines (Mykhaylyk et al., 2007; Prijic and Sersa, 2011).
Althoughmagnetofectionresults arepromising in vitro, andsev-
eral studies have reported the systemic delivery of nucleic acids
usingMNPs in vivo, notmanyof themuse anexternalmagnetic
field to enhance the accumulation of theMNPs in the targeted
area (Plank et al., 2011). Thus far, the most promising appli-
cation ofmagnetofection as an in vivo cancer therapy has been
reported byNamiki et al. (2009). The authors formulated oleic
acid-coatedMNPsassembledwithcationic lipidshells, andfunc-
tionalized themwith an appropriate siRNA sequence to knock
down the epidermal growth factor receptor (EGFR)mRNA, as
it is overexpressed in tumorbloodvessel endothelium.After sys-
temicallyinjectingthecomplextomicetumors,theauthorsfound
a50%reductionintumormasswhenamagneticfieldwasapplied
comparedto thecontrolgroupwithoutmagneticfield.
Peptides
Peptides are short chains of amino acid monomers linked by
amide bonds and are distinguished from proteins on the basis
of size, once theyonly contain∼50aminoacidsor less. Peptides
canbe foundnaturallyor syntheticallyandhave thepotential for
the stabilization and biofunctionalization of NPs. For instance
Wang et al. demonstrate thatmultiple functional peptide stabi-
lized AuNPs are readily obtained in a one-step surface coating
procedure and that the surface functionalities can be selectively
addressedonamicroarray.The authors developed a straightfor-
ward route to stableAuNPs, bothwith single andwithdual bio-
logical functionality.Theparticlesexhibit thespecificrecognition
Frontiers inChemistry | ChemicalEngineering July2014 |Volume2 |Article48 | 15
Cancer Nanotheranostics
What Have We Learnd So Far?
- Titel
- Cancer Nanotheranostics
- Untertitel
- What Have We Learnd So Far?
- Autoren
- João Conde
- Pedro Viana Baptista
- Jesús M. De La Fuente
- Furong Tian
- Herausgeber
- Frontiers in Chemistry
- Datum
- 2016
- Sprache
- englisch
- Lizenz
- CC BY 4.0
- ISBN
- 978-2-88919-776-7
- Abmessungen
- 21.0 x 27.7 cm
- Seiten
- 132
- Schlagwörter
- Nanomedicine, Nanoparticles, nanomaterials, Cancer, heranostics, Immunotherapy, bioimaging, Drug delivery, Gene Therapy, Phototherapy
- Kategorien
- Naturwissenschaften Chemie